141 related articles for article (PubMed ID: 20828604)
1. Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat.
Al-Subeihi AA; Spenkelink B; Rachmawati N; Boersma MG; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Toxicol In Vitro; 2011 Feb; 25(1):267-85. PubMed ID: 20828604
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat.
Punt A; Freidig AP; Delatour T; Scholz G; Boersma MG; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2008 Sep; 231(2):248-59. PubMed ID: 18539307
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat.
Al-Subeihi AA; Spenkelink B; Punt A; Boersma MG; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2012 May; 260(3):271-84. PubMed ID: 22445790
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
Al-Subeihi AA; Alhusainy W; Paini A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Food Chem Toxicol; 2013 Sep; 59():564-71. PubMed ID: 23831728
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
[TBL] [Abstract][Full Text] [Related]
7. Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats.
Punt A; Paini A; Boersma MG; Freidig AP; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2009 Aug; 110(2):255-69. PubMed ID: 19447879
[TBL] [Abstract][Full Text] [Related]
8. A comparative in vitro kinetic study of [14C]-eugenol and [14C]-methyleugenol activation and detoxification in human, mouse, and rat liver and lung fractions.
Minet EF; Daniela G; Meredith C; Massey ED
Xenobiotica; 2012 May; 42(5):429-41. PubMed ID: 22188410
[TBL] [Abstract][Full Text] [Related]
9. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol.
Jeurissen SM; Bogaards JJ; Boersma MG; ter Horst JP; Awad HM; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2006 Jan; 19(1):111-6. PubMed ID: 16411663
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based biokinetic (PBBK) modeling of safrole bioactivation and detoxification in humans as compared with rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Sci; 2012 Aug; 128(2):301-16. PubMed ID: 22588462
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
[TBL] [Abstract][Full Text] [Related]
12. In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: implications for risk assessment.
Rietjens IM; Punt A; Schilter B; Scholz G; Delatour T; van Bladeren PJ
Mol Nutr Food Res; 2010 Feb; 54(2):195-207. PubMed ID: 19943261
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based kinetic models for the alkenylbenzene elemicin in rat and human and possible implications for risk assessment.
van den Berg SJ; Punt A; Soffers AE; Vervoort J; Ngeleja S; Spenkelink B; Rietjens IM
Chem Res Toxicol; 2012 Nov; 25(11):2352-67. PubMed ID: 22992039
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
Gardner I; Bergin P; Stening P; Kenna JG; Caldwell J
Chem Res Toxicol; 1996 Jun; 9(4):713-21. PubMed ID: 8831815
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.
Cartus AT; Herrmann K; Weishaupt LW; Merz KH; Engst W; Glatt H; Schrenk D
Toxicol Sci; 2012 Sep; 129(1):21-34. PubMed ID: 22610610
[TBL] [Abstract][Full Text] [Related]
17. The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat.
Alhusainy W; Williams GM; Jeffrey AM; Iatropoulos MJ; Taylor S; Adams TB; Rietjens IM
Food Chem Toxicol; 2014 Dec; 74():28-34. PubMed ID: 25218219
[TBL] [Abstract][Full Text] [Related]
18. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods.
Herrmann K; Engst W; Appel KE; Monien BH; Glatt H
Mutagenesis; 2012 Jul; 27(4):453-62. PubMed ID: 22337896
[TBL] [Abstract][Full Text] [Related]
19. Matrix modulation of the bioactivation of estragole by constituents of different alkenylbenzene-containing herbs and spices and physiologically based biokinetic modeling of possible in vivo effects.
Alhusainy W; van den Berg SJ; Paini A; Campana A; Asselman M; Spenkelink A; Punt A; Scholz G; Schilter B; Adams TB; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2012 Sep; 129(1):174-87. PubMed ID: 22649189
[TBL] [Abstract][Full Text] [Related]
20. Genotoxic potential of methyleugenol and selected methyleugenol metabolites in cultured Chinese hamster V79 cells.
Groh IA; Cartus AT; Vallicotti S; Kajzar J; Merz KH; Schrenk D; Esselen M
Food Funct; 2012 Apr; 3(4):428-36. PubMed ID: 22302122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
